Stock TAK TAKEDA PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Takeda Pharmaceutical Company Limited Nyse

Equities

TAK

US8740602052

Real-time Estimate Cboe BZX
Other stock markets
 03:45:04 2024-07-11 pm EDT 		5-day change 1st Jan Change
13.4 USD +1.09% Intraday chart for Takeda Pharmaceutical Company Limited +1.25% -6.27%
Jul. 09 Takeda Issues New Shares, Disposes of Treasury Shares Under Incentive Scheme MT
Jul. 03 Blackstone selling Japan drugmaker Alinamin to MBK Partners RE

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Takeda Issues New Shares, Disposes of Treasury Shares Under Incentive Scheme
MT
Blackstone selling Japan drugmaker Alinamin to MBK Partners
RE
Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan
MT
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan
CI
Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics
MT
Corza Medical Inc. completed the acquisition of TachoSil manufacturing operations in Linz, Austria. from Takeda Pharmaceutical Company Limited.
CI
US CDC alerts healthcare providers of increase in dengue cases
RE
Hutchmed (China), Takeda Secure EU Approval for Colorectal Cancer Treatment
MT
Takeda Announces Approval of LIVTENCITY® by the Japanese Ministry of Health, Labour and Welfare
CI
Takeda Receives European Commission Approval for FRUZAQLA® (fruquintinib)
CI
Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
CI
Takeda Secures European Commission's Approval for Colorectal Cancer Drug Fruzaqla
MT
Takeda Receives Approval from European Commission for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
CI
Japanese Stocks End Little Changed After Three-Day Winning Streak on Inflation and Yen Woes
MT
Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India
RE
Sun Pharma Signs Deal with Japan's Takeda to Commercialize Vonoprazan in India
MT
Sun Pharma Signs Non-Exclusive Patent Licensing Agreement with Takeda for Introducing Novel Gastrointestinal Drug, Voltapraz in India
CI
Takeda Pharmaceutical Says Results of Phase 3 Trial Support Use of Hyqvia as Maintenance Treatment for CIDP
MT
Takeda Announces Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA in Patients with Chronic Inflammatory Demyelinating Polyneuropathy at PNS Annual Meeting
CI
Ovid Therapeutics Shares Slide Premarket After Takeda's Soticlestat Setback
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. TAK Stock
  5. News Takeda Pharmaceutical Company Limited
  6. Highlights